Over the past ten days of trading, CRISPR Therapeutics AG (NASDAQ: CRSP), from June 18, 2026 to July 02, 2026 there is a potential Short Squeeze about to happen because of an increase in short volume over the past ten days with very little cover volume.
Because of this the Squeeze Report trend indicator issued a CRSP Short Squeeze.
CRISPR Therapeutics AG (NASDAQ: CRSP) Short Squeeze Analysis
During the last five days of trading, from June 26, 2026 to July 02, 2026 CRSP had a staggering 1,876,569 shares shorted while trading a total of 5,413,188 shares as show the on CRSP short page.
The last ten days of trading, from June 18, 2026 to July 02, 2026 CRSP had a staggering 3,496,148 shares shorted while trading a total of 9,175,999 shares as show the on CRSP short page.
According to our proprietary algorithm during the last five trading days there were 5 short days, 0 days with no change but 0 cover days. Over the last ten trading days there were 10 short days, 0 days with no change but 0 cover days.
CRISPR Therapeutics AG (NASDAQ: CRSP) Short Squeeze Result
The short indicator utilizes several factors before determining a result and because of these indications we have placed a short trend indicator of CRSP Short Squeeze.
CRISPR Therapeutics AG (NASDAQ: CRSP) Short Squeeze Data
Ten Day trading Totals
| Total Shorted Volume | 3,496,148 |
| Total Actual Volume | 9,175,999 |
| Total Volume Discrepancy | 2,396,807 |
Short Trends
| Cover Days | 0 |
| Short Days | 10 |
| No Change Days | 0 |
Averages
| Average Volume Discrepancy | 239,680 |
| Average Short Volume | 349,614 |
| Average Short Percentage | 51% |
The Short Trend Indicator
Squeeze Reports short trend indicator utilizes several different trading factors including, short data, trade data, short analysis and short probability. So become a member of Squeeze Report if you want to to gain access or know more about the short trend indicator and other short trading tools.
CRISPR Therapeutics AG (NASDAQ: CRSP) Chart
Disclaimer
This article is for the purposes of solicitation subscriptions for Squeeze Report. The company Squeeze Report expects to generate new advertisement revenue resulting from the distribution of this article. The amount of which is unknown at this time. Squeeze Report or it’s authors do not own any shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and does not buy, sell, or trade any shares of CRSP. This article does not provide a professional analysis of a (CRSP) financial position. (CRSP) financial position and all other information regarding the featured Company should be verified directly with (CRSP). Squeeze Report has received none USD from N/A for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting N/A ending N/A. Please read our full disclaimer for more detailed information.
